TAKEDA PHARMACEUTICAL CO LTD

13F Portfolio Filings

Most recent 13F
Q4 2024
Location
Tokyo, Japan
CIK
0001395064
All SEC filings
View on sec.gov
Holdings Value
Quarter Holdings Value ($000) Top Holdings Form Type Date Filed Filing ID
Q4 2024 11 26,564 HLVX, OVID, XLO, EQ 13F-HR 2/12/2025 000139506425000019
Q3 2024 10 37,950 HLVX, WVE, OVID, STTK 13F-HR 2/13/2025 000139506425000030
Q2 2024 13 232,311 DNLI, HLVX, PHAT, WVE 13F-HR 2/13/2025 000139506425000028
Q1 2024 15 289,040 HLVX, DNLI, PHAT, OVID 13F-HR 2/13/2025 000139506425000026
Q4 2023 14 327,499 HLVX, DNLI, PHAT, OVID 13F-HR 2/13/2025 000139506425000024